SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-177081
Filing Date
2022-06-21
Accepted
2022-06-21 08:05:35
Documents
6
Effectiveness Date
2022-06-21

Document Format Files

Seq Description Document Type Size
1 S-8 d307046ds8.htm S-8 48850
2 EX-5.1 d307046dex51.htm EX-5.1 6240
3 EX-23.2 d307046dex232.htm EX-23.2 1619
4 EX-23.3 d307046dex233.htm EX-23.3 1555
5 EX-FILING FEES d307046dexfilingfees.htm EX-FILING FEES 24240
6 GRAPHIC g307046cooley.jpg GRAPHIC 3673
  Complete submission text file 0001193125-22-177081.txt   88948
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265718 | Film No.: 221026108
SIC: 2834 Pharmaceutical Preparations